InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,308.13
(
0.00%
)
US TECH 100
18,141.60
(
-0.30%
)
Dow Jones
39,806.77
(
0.00%
)
Brent Oil
82.54
(
-1.19%
)
Bitcoin
70,952.43
(
-0.70%
)
Post# of 424401
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

sharinky

Send PM Follow Ignore
Followers 7
Posts 1173
Boards Moderated 0
Alias Born 11/13/2018

sharinky

Re: jessellivermore post# 228016

Tuesday, 11/19/2019 6:59:57 AM

Tuesday, November 19, 2019 6:59:57 AM

Post# of 424401
Many Medicare Part D plans do not have Vascepa in their formulary because they are not required by regulation to have it there. Lobbyist need to get the regulations changed in conjunction with the new label.

You and others might consider contacting AARP with what is going on. They should know specifically what needs to be changed. In addition to the AHA, ADA etc, I believe the AARP could take this on, on behalf of Medicare patients. It will be the only drug with CVOT outcomes trial for an indication and Medicare patients should have reasonable access to this safe effective drug. Once we have the real label indication in December it will be easier but if they are not working on it now they should be.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AMRN News
More AMRN News
InvestorsHub NewsWire

North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM

Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM

Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM

VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM

ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM

Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM

Start posting your company's news
Only $200 per official company press release!